In sum, this study has identified SMAD3 and BGN as novel RAC1B target genes in pancreatic cancer cells with SMAD3, in an activation-independent manner, inducing BGN, which subsequently executes inhibition of cell motility in TGF-β-dependent and/or independent fashion. Here, BGN is linked to pancreatic neoplasm.